Submit Search
Upload
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner by Patricia B. Cerrito
•
Download as PPT, PDF
•
2 likes
•
813 views
C
cambridgeWD
Follow
Health & Medicine
Technology
Report
Share
Report
Share
1 of 62
Download now
Recommended
Lecture on clinical decision making to the Jacobi Medical Center / AECOM Internal Medicine Residents using examples from the COVID-19 literature.
Statistics in clinical and translational research common pitfalls
Statistics in clinical and translational research common pitfalls
Pavlos Msaouel, MD, PhD
Lecture on causal inference to the pediatric hematology/oncology fellows at Texas Children's hospital as part of their Biostatistics for Busy Clinicians lecture seriers.
Causal inference lecture to Texas Children's fellows
Causal inference lecture to Texas Children's fellows
Pavlos Msaouel, MD, PhD
Power Analysis and Sample Size Determination
Power Analysis and Sample Size Determination
Ajay Dhamija
Sample size calculation for medical research - a brief overview
Sample size calculation - a brief overview
Sample size calculation - a brief overview
Azmi Mohd Tamil
Task: To build multiple regression and logistic regression models on appropriate data. Approach: A general topic was selected first after which the data was downloaded from the source keeping the restrictions in mind and then cleaned in R. Then the multiple regression and logistic regression models were built using IBM SPSS and the outputs were interpreted. The dependent variable was life expectancy and the independent variables were Age-standardized Mortality-Communicable”, “Age-standardized Mortality-Cardiovascular Disease and Diabetes". Findings: Multipleregression - analysis was conducted to make sure normality, linearity, multi-collinearity, independence of errors and homoscedasticity were not violated. Statistically, the score of Life expectancy at age 60, 퐹(2,102) = 39.474 푅2 = .436, 푝 < 0.0005 Logistic Regression: Result shows 58.9% (Cox & Snell R-Square) and 80.1% (Nagelkerke R-Square) of the variance and gives 92.4% of correctly classified countries. The two indicating factors made a remarkable commitment to the model. Also, the model predicts the increase in “Mortality-Cardiovascular/Diabetes” and “Mortality rate cause by Communicable” variables is the cause of a decrease in Life Expectancy in a country. Tools: IBM SPSS
Statistics For Data Analytics - Multiple & logistic regression
Statistics For Data Analytics - Multiple & logistic regression
Shrikant Samarth
In order to understand medical statistics, you have to learn the very basic concepts as mean, median, and standard deviation. interpretation and understanding of clinical study results depends mainly on statistical background.
Introduction to medical statistics
Introduction to medical statistics
Mohamed Alhelaly
Lori Chibnik, PhD
Biostatistics Workshop: Sample Size & Power
Biostatistics Workshop: Sample Size & Power
HopkinsCFAR
Basics of medical statistics
Basics of medical statistics
Basics of medical statistics
Ramachandra Barik
Recommended
Lecture on clinical decision making to the Jacobi Medical Center / AECOM Internal Medicine Residents using examples from the COVID-19 literature.
Statistics in clinical and translational research common pitfalls
Statistics in clinical and translational research common pitfalls
Pavlos Msaouel, MD, PhD
Lecture on causal inference to the pediatric hematology/oncology fellows at Texas Children's hospital as part of their Biostatistics for Busy Clinicians lecture seriers.
Causal inference lecture to Texas Children's fellows
Causal inference lecture to Texas Children's fellows
Pavlos Msaouel, MD, PhD
Power Analysis and Sample Size Determination
Power Analysis and Sample Size Determination
Ajay Dhamija
Sample size calculation for medical research - a brief overview
Sample size calculation - a brief overview
Sample size calculation - a brief overview
Azmi Mohd Tamil
Task: To build multiple regression and logistic regression models on appropriate data. Approach: A general topic was selected first after which the data was downloaded from the source keeping the restrictions in mind and then cleaned in R. Then the multiple regression and logistic regression models were built using IBM SPSS and the outputs were interpreted. The dependent variable was life expectancy and the independent variables were Age-standardized Mortality-Communicable”, “Age-standardized Mortality-Cardiovascular Disease and Diabetes". Findings: Multipleregression - analysis was conducted to make sure normality, linearity, multi-collinearity, independence of errors and homoscedasticity were not violated. Statistically, the score of Life expectancy at age 60, 퐹(2,102) = 39.474 푅2 = .436, 푝 < 0.0005 Logistic Regression: Result shows 58.9% (Cox & Snell R-Square) and 80.1% (Nagelkerke R-Square) of the variance and gives 92.4% of correctly classified countries. The two indicating factors made a remarkable commitment to the model. Also, the model predicts the increase in “Mortality-Cardiovascular/Diabetes” and “Mortality rate cause by Communicable” variables is the cause of a decrease in Life Expectancy in a country. Tools: IBM SPSS
Statistics For Data Analytics - Multiple & logistic regression
Statistics For Data Analytics - Multiple & logistic regression
Shrikant Samarth
In order to understand medical statistics, you have to learn the very basic concepts as mean, median, and standard deviation. interpretation and understanding of clinical study results depends mainly on statistical background.
Introduction to medical statistics
Introduction to medical statistics
Mohamed Alhelaly
Lori Chibnik, PhD
Biostatistics Workshop: Sample Size & Power
Biostatistics Workshop: Sample Size & Power
HopkinsCFAR
Basics of medical statistics
Basics of medical statistics
Basics of medical statistics
Ramachandra Barik
[Webinar] How to reduce sample size...ethically and responsibly | In this free webinar, you will learn various design strategies to help reduce the sample size of your study in an ethical and responsible manner. Practical examples will be used throughout.
Webinar slides how to reduce sample size ethically and responsibly
Webinar slides how to reduce sample size ethically and responsibly
nQuery
Due to the advancements in various data acquisition and storage technologies, different disciplines have attained the ability to not only accumulate a wide variety of data but also to monitor observations over longer time periods. In many real-world applications, the primary objective of monitoring these observations is to estimate when a particular event of interest will occur in the future. One of the major difficulties in handling such problem is the presence of censoring, i.e., the event of interests is unobservable in some instance which is either because of time limitation or losing track. Due to censoring, standard statistical and machine learning based predictive models cannot readily be applied to analyze the data. An important subfield of statistics called survival analysis provides different mechanisms to handle such censored data problems. In addition to the presence of censoring, such time-to-event data also encounters several other research challenges such as instance/feature correlations, high-dimensionality, temporal dependencies, and difficulty in acquiring sufficient event data in a reasonable amount of time. To tackle such practical concerns, the data mining and machine learning communities have started to develop more sophisticated and effective algorithms that either complement or compete with the traditional statistical methods in survival analysis. In spite of the importance of this problem and relevance to real-world applications, this research topic is scattered across various disciplines. In this tutorial, we will provide a comprehensive and structured overview of both statistical and machine learning based survival analysis methods along with different applications. We will also discuss the commonly used evaluation metrics and other related topics. The material will be coherently organized and presented to help the audience get a clear picture of both the fundamentals and the state-of-the-art techniques.
Machine Learning for Survival Analysis
Machine Learning for Survival Analysis
Chandan Reddy
Sample size calculation final
Sample size calculation final
Bhaswat Chakraborty
Power and sample size calculations for survival analysis webinar
Power and sample size calculations for survival analysis webinar Slides
Power and sample size calculations for survival analysis webinar Slides
nQuery
Chapter 4(1) Basic Logic
Chapter 4(1) Basic Logic
ghalan
Chapter 4(1) Basic Logic
Chapter 4(1) Basic Logic
Sumit Prajapati
Part 8 of 9; 8.Calculate samplesize for clinical trials (continuous outcome)
8.Calculate samplesize for clinical trials (continuous outcome)
8.Calculate samplesize for clinical trials (continuous outcome)
Azmi Mohd Tamil
Sample size calculation
Sample size calculation
Sample size calculation
Ramachandra Barik
[ Watch Webinar: http://bit.ly/2thIgmi ]. In this free webinar, Head of Statistics at Statsols, Ronan Fitzpatrick, addresses the issues of reducing risk in Phase II/III sample size calculations. Topics covered will include: Sample Size Determination For Different Trial Designs Bayesian Sample Size Determination Sample Size For Survival Analysis & more
Minimizing Risk In Phase II and III Sample Size Calculation
Minimizing Risk In Phase II and III Sample Size Calculation
nQuery
About the webinar This webinar examines the role of non-inferiority and equivalence in study design In this free webinar, you will learn about: -Regulatory information on this type of study design -Considerations for study design and your sample size -Practical worked examples of --Non-inferiority Testing --Equivalence Testing Duration - 60 minutes Speaker: Ronan Fitzpatrick, Head of Statistics, Statsols Watch the video at: https://www.statsols.com/webinars
Non-inferiority and Equivalence Study design considerations and sample size
Non-inferiority and Equivalence Study design considerations and sample size
nQuery
Distribuição Amostral
Brmedj00047 0038
Brmedj00047 0038
Waleska Monteiro
Determining the appropriate number of events needed for survival analysis is a complex task as study planners try to predict what sample size will be needed after accounting for the complications of unequal follow-up, drop-out and treatment crossover. The statistical, logistical and ethical considerations all complicate life for biostatisticians as issues to balance in planning a survival analysis. However, this complexity has created a need for new analyses and procedures to help the planning process for survival analysis trials. The wider move from fixed to flexible designs has opened up opportunities for advanced methods such as adaptive design and Bayesian analysis to help deal with the unique complications of planning for survival data but these methods have their own complications that need to be explored too.
Sample size for survival analysis - a guide to planning successful clinical t...
Sample size for survival analysis - a guide to planning successful clinical t...
nQuery
2020 Trends In Biostatistics - What you should know about study design. In this free webinar you will learn about: -Adaptive designs in confirmatory trials -Using external data in study planning -Innovative designs in early-stage trials To watch the full webinar: https://www.statsols.com/webinar/2020-trends-in-biostatistics-what-you-should-know-about-study-design
2020 trends in biostatistics what you should know about study design - slid...
2020 trends in biostatistics what you should know about study design - slid...
nQuery
Sample size
6. sample size v3
6. sample size v3
Ashok Kulkarni
Sample size
Sample size
Har Jindal
A discussion of the role of clinical trials in the age of COVID. My contribution to the phastar 2020 life sciences summit https://phastar.com/phastar-life-science-summit
Clinical trials: quo vadis in the age of covid?
Clinical trials: quo vadis in the age of covid?
Stephen Senn
Mortality after primary PCI: a novel risk model including vascular access site: the ALPHA score - Istvan Hizoh
06 Hizoh aimradial20170921 Mortality risk
06 Hizoh aimradial20170921 Mortality risk
International Chair on Interventional Cardiology and Transradial Approach
"Innovative Sample Size Methods for Clinical Trials" is hosted to coincide with the Spring 2018 update to nQuery - The leading Sample Size Software. Hosted by Ronan Fitzpatrick - Head of Statistics and nQuery Lead Researcher at Statsols - you'll learn about the benefits of a range of procedures and how you can implement them into your work: 1) Dose-escalation with the Bayesian Continual Reassessment Method CRM is a growing alternative to the 3+3 method for Phase I trials finding the Maximum Tolerated Dose (MTD). See how researchers can overcome 3+3 drawbacks to easily find the required sample size for this beneficial alternative for finding the MTD. 2) Bayesian Assurance with Survival Example This Bayesian alternative to power has experienced a rapid rise in interest and application from researchers. See how Assurance is being used by researchers to discover the true “probability of success” of a trial. 3) Mendelian Randomization Mendelian randomization (MR) is a method that allows testing of a causal effect from observational data in the presence of confounding factors. However, in order to design efficient Mendelian randomization studies, it is essential to calculate the appropriate sample sizes required. We demonstrate what to do to achieve this. 4) Negative Binomial Distribution Negative binomial model has been increasingly used to model the count data. One of the challenges of applying negative binomial model in clinical trial design is the sample size estimation. We demonstrate how best to determine the appropriate sample size in the presence of challenges such as unequal follow-up or dispersion.
Innovative Sample Size Methods For Clinical Trials
Innovative Sample Size Methods For Clinical Trials
nQuery
Hechsp 001 Chapter 3
Hechsp 001 Chapter 3
Brian Kelly
Sas Enterprise Guide A Revolutionary Tool
Sas Enterprise Guide A Revolutionary Tool
sysseminar
Proc SQL in SAS Enterprise Guide 4.3
Proc SQL in SAS Enterprise Guide 4.3
Mark Tabladillo
Learning Base SAS, Advanced SAS, Proc SQl, ODS, SAS in financial industry, Clinical trials, SAS Macros, SAS BI, SAS on Unix, SAS on Mainframe, SAS interview Questions and Answers, SAS Tips and Techniques, SAS Resources, SAS Certification questions... visit http://sastechies.blogspot.com
SAS Access / SAS Connect
SAS Access / SAS Connect
guest2160992
More Related Content
What's hot
[Webinar] How to reduce sample size...ethically and responsibly | In this free webinar, you will learn various design strategies to help reduce the sample size of your study in an ethical and responsible manner. Practical examples will be used throughout.
Webinar slides how to reduce sample size ethically and responsibly
Webinar slides how to reduce sample size ethically and responsibly
nQuery
Due to the advancements in various data acquisition and storage technologies, different disciplines have attained the ability to not only accumulate a wide variety of data but also to monitor observations over longer time periods. In many real-world applications, the primary objective of monitoring these observations is to estimate when a particular event of interest will occur in the future. One of the major difficulties in handling such problem is the presence of censoring, i.e., the event of interests is unobservable in some instance which is either because of time limitation or losing track. Due to censoring, standard statistical and machine learning based predictive models cannot readily be applied to analyze the data. An important subfield of statistics called survival analysis provides different mechanisms to handle such censored data problems. In addition to the presence of censoring, such time-to-event data also encounters several other research challenges such as instance/feature correlations, high-dimensionality, temporal dependencies, and difficulty in acquiring sufficient event data in a reasonable amount of time. To tackle such practical concerns, the data mining and machine learning communities have started to develop more sophisticated and effective algorithms that either complement or compete with the traditional statistical methods in survival analysis. In spite of the importance of this problem and relevance to real-world applications, this research topic is scattered across various disciplines. In this tutorial, we will provide a comprehensive and structured overview of both statistical and machine learning based survival analysis methods along with different applications. We will also discuss the commonly used evaluation metrics and other related topics. The material will be coherently organized and presented to help the audience get a clear picture of both the fundamentals and the state-of-the-art techniques.
Machine Learning for Survival Analysis
Machine Learning for Survival Analysis
Chandan Reddy
Sample size calculation final
Sample size calculation final
Bhaswat Chakraborty
Power and sample size calculations for survival analysis webinar
Power and sample size calculations for survival analysis webinar Slides
Power and sample size calculations for survival analysis webinar Slides
nQuery
Chapter 4(1) Basic Logic
Chapter 4(1) Basic Logic
ghalan
Chapter 4(1) Basic Logic
Chapter 4(1) Basic Logic
Sumit Prajapati
Part 8 of 9; 8.Calculate samplesize for clinical trials (continuous outcome)
8.Calculate samplesize for clinical trials (continuous outcome)
8.Calculate samplesize for clinical trials (continuous outcome)
Azmi Mohd Tamil
Sample size calculation
Sample size calculation
Sample size calculation
Ramachandra Barik
[ Watch Webinar: http://bit.ly/2thIgmi ]. In this free webinar, Head of Statistics at Statsols, Ronan Fitzpatrick, addresses the issues of reducing risk in Phase II/III sample size calculations. Topics covered will include: Sample Size Determination For Different Trial Designs Bayesian Sample Size Determination Sample Size For Survival Analysis & more
Minimizing Risk In Phase II and III Sample Size Calculation
Minimizing Risk In Phase II and III Sample Size Calculation
nQuery
About the webinar This webinar examines the role of non-inferiority and equivalence in study design In this free webinar, you will learn about: -Regulatory information on this type of study design -Considerations for study design and your sample size -Practical worked examples of --Non-inferiority Testing --Equivalence Testing Duration - 60 minutes Speaker: Ronan Fitzpatrick, Head of Statistics, Statsols Watch the video at: https://www.statsols.com/webinars
Non-inferiority and Equivalence Study design considerations and sample size
Non-inferiority and Equivalence Study design considerations and sample size
nQuery
Distribuição Amostral
Brmedj00047 0038
Brmedj00047 0038
Waleska Monteiro
Determining the appropriate number of events needed for survival analysis is a complex task as study planners try to predict what sample size will be needed after accounting for the complications of unequal follow-up, drop-out and treatment crossover. The statistical, logistical and ethical considerations all complicate life for biostatisticians as issues to balance in planning a survival analysis. However, this complexity has created a need for new analyses and procedures to help the planning process for survival analysis trials. The wider move from fixed to flexible designs has opened up opportunities for advanced methods such as adaptive design and Bayesian analysis to help deal with the unique complications of planning for survival data but these methods have their own complications that need to be explored too.
Sample size for survival analysis - a guide to planning successful clinical t...
Sample size for survival analysis - a guide to planning successful clinical t...
nQuery
2020 Trends In Biostatistics - What you should know about study design. In this free webinar you will learn about: -Adaptive designs in confirmatory trials -Using external data in study planning -Innovative designs in early-stage trials To watch the full webinar: https://www.statsols.com/webinar/2020-trends-in-biostatistics-what-you-should-know-about-study-design
2020 trends in biostatistics what you should know about study design - slid...
2020 trends in biostatistics what you should know about study design - slid...
nQuery
Sample size
6. sample size v3
6. sample size v3
Ashok Kulkarni
Sample size
Sample size
Har Jindal
A discussion of the role of clinical trials in the age of COVID. My contribution to the phastar 2020 life sciences summit https://phastar.com/phastar-life-science-summit
Clinical trials: quo vadis in the age of covid?
Clinical trials: quo vadis in the age of covid?
Stephen Senn
Mortality after primary PCI: a novel risk model including vascular access site: the ALPHA score - Istvan Hizoh
06 Hizoh aimradial20170921 Mortality risk
06 Hizoh aimradial20170921 Mortality risk
International Chair on Interventional Cardiology and Transradial Approach
"Innovative Sample Size Methods for Clinical Trials" is hosted to coincide with the Spring 2018 update to nQuery - The leading Sample Size Software. Hosted by Ronan Fitzpatrick - Head of Statistics and nQuery Lead Researcher at Statsols - you'll learn about the benefits of a range of procedures and how you can implement them into your work: 1) Dose-escalation with the Bayesian Continual Reassessment Method CRM is a growing alternative to the 3+3 method for Phase I trials finding the Maximum Tolerated Dose (MTD). See how researchers can overcome 3+3 drawbacks to easily find the required sample size for this beneficial alternative for finding the MTD. 2) Bayesian Assurance with Survival Example This Bayesian alternative to power has experienced a rapid rise in interest and application from researchers. See how Assurance is being used by researchers to discover the true “probability of success” of a trial. 3) Mendelian Randomization Mendelian randomization (MR) is a method that allows testing of a causal effect from observational data in the presence of confounding factors. However, in order to design efficient Mendelian randomization studies, it is essential to calculate the appropriate sample sizes required. We demonstrate what to do to achieve this. 4) Negative Binomial Distribution Negative binomial model has been increasingly used to model the count data. One of the challenges of applying negative binomial model in clinical trial design is the sample size estimation. We demonstrate how best to determine the appropriate sample size in the presence of challenges such as unequal follow-up or dispersion.
Innovative Sample Size Methods For Clinical Trials
Innovative Sample Size Methods For Clinical Trials
nQuery
What's hot
(18)
Webinar slides how to reduce sample size ethically and responsibly
Webinar slides how to reduce sample size ethically and responsibly
Machine Learning for Survival Analysis
Machine Learning for Survival Analysis
Sample size calculation final
Sample size calculation final
Power and sample size calculations for survival analysis webinar Slides
Power and sample size calculations for survival analysis webinar Slides
Chapter 4(1) Basic Logic
Chapter 4(1) Basic Logic
Chapter 4(1) Basic Logic
Chapter 4(1) Basic Logic
8.Calculate samplesize for clinical trials (continuous outcome)
8.Calculate samplesize for clinical trials (continuous outcome)
Sample size calculation
Sample size calculation
Minimizing Risk In Phase II and III Sample Size Calculation
Minimizing Risk In Phase II and III Sample Size Calculation
Non-inferiority and Equivalence Study design considerations and sample size
Non-inferiority and Equivalence Study design considerations and sample size
Brmedj00047 0038
Brmedj00047 0038
Sample size for survival analysis - a guide to planning successful clinical t...
Sample size for survival analysis - a guide to planning successful clinical t...
2020 trends in biostatistics what you should know about study design - slid...
2020 trends in biostatistics what you should know about study design - slid...
6. sample size v3
6. sample size v3
Sample size
Sample size
Clinical trials: quo vadis in the age of covid?
Clinical trials: quo vadis in the age of covid?
06 Hizoh aimradial20170921 Mortality risk
06 Hizoh aimradial20170921 Mortality risk
Innovative Sample Size Methods For Clinical Trials
Innovative Sample Size Methods For Clinical Trials
Viewers also liked
Hechsp 001 Chapter 3
Hechsp 001 Chapter 3
Brian Kelly
Sas Enterprise Guide A Revolutionary Tool
Sas Enterprise Guide A Revolutionary Tool
sysseminar
Proc SQL in SAS Enterprise Guide 4.3
Proc SQL in SAS Enterprise Guide 4.3
Mark Tabladillo
Learning Base SAS, Advanced SAS, Proc SQl, ODS, SAS in financial industry, Clinical trials, SAS Macros, SAS BI, SAS on Unix, SAS on Mainframe, SAS interview Questions and Answers, SAS Tips and Techniques, SAS Resources, SAS Certification questions... visit http://sastechies.blogspot.com
SAS Access / SAS Connect
SAS Access / SAS Connect
guest2160992
Learning Base SAS, Advanced SAS, Proc SQl, ODS, SAS in financial industry, Clinical trials, SAS Macros, SAS BI, SAS on Unix, SAS on Mainframe, SAS interview Questions and Answers, SAS Tips and Techniques, SAS Resources, SAS Certification questions... visit http://sastechies.blogspot.com
Utility Procedures in SAS
Utility Procedures in SAS
guest2160992
Learning Base SAS, Advanced SAS, Proc SQl, ODS, SAS in financial industry, Clinical trials, SAS Macros, SAS BI, SAS on Unix, SAS on Mainframe, SAS interview Questions and Answers, SAS Tips and Techniques, SAS Resources, SAS Certification questions... visit http://sastechies.blogspot.com
SAS Macros
SAS Macros
guest2160992
Learning Base SAS, Advanced SAS, Proc SQl, ODS, SAS in financial industry, Clinical trials, SAS Macros, SAS BI, SAS on Unix, SAS on Mainframe, SAS interview Questions and Answers, SAS Tips and Techniques, SAS Resources, SAS Certification questions... visit http://sastechies.blogspot.com
Base SAS Statistics Procedures
Base SAS Statistics Procedures
guest2160992
SAS Macros part 1
SAS Macros part 1
venkatam
Learning Base SAS, Advanced SAS, Proc SQl, ODS, SAS in financial industry, Clinical trials, SAS Macros, SAS BI, SAS on Unix, SAS on Mainframe, SAS interview Questions and Answers, SAS Tips and Techniques, SAS Resources, SAS Certification questions... visit http://sastechies.blogspot.com
SAS Proc SQL
SAS Proc SQL
guest2160992
Learning Base SAS, Advanced SAS, Proc SQl, ODS, SAS in financial industry, Clinical trials, SAS Macros, SAS BI, SAS on Unix, SAS on Mainframe, SAS interview Questions and Answers, SAS Tips and Techniques, SAS Resources, SAS Certification questions... visit http://sastechies.blogspot.com
Understanding SAS Data Step Processing
Understanding SAS Data Step Processing
guest2160992
Learning Base SAS, Advanced SAS, Proc SQl, ODS, SAS in financial industry, Clinical trials, SAS Macros, SAS BI, SAS on Unix, SAS on Mainframe, SAS interview Questions and Answers, SAS Tips and Techniques, SAS Resources, SAS Certification questions... visit http://sastechies.blogspot.com
Basics Of SAS Programming Language
Basics Of SAS Programming Language
guest2160992
Regression analysis
Regression analysis
saba khan
Chap
Regression Analysis
Regression Analysis
nadiazaheer
SAS Basics SAS Data manipulations SAS Procs and Functions
SAS basics Step by step learning
SAS basics Step by step learning
Venkata Reddy Konasani
Regression analysis
Regression analysis
Ravi shankar
Statistics
Statistics
pikuoec
Regression analysis ppt
Regression analysis ppt
Elkana Rorio
Viewers also liked
(17)
Hechsp 001 Chapter 3
Hechsp 001 Chapter 3
Sas Enterprise Guide A Revolutionary Tool
Sas Enterprise Guide A Revolutionary Tool
Proc SQL in SAS Enterprise Guide 4.3
Proc SQL in SAS Enterprise Guide 4.3
SAS Access / SAS Connect
SAS Access / SAS Connect
Utility Procedures in SAS
Utility Procedures in SAS
SAS Macros
SAS Macros
Base SAS Statistics Procedures
Base SAS Statistics Procedures
SAS Macros part 1
SAS Macros part 1
SAS Proc SQL
SAS Proc SQL
Understanding SAS Data Step Processing
Understanding SAS Data Step Processing
Basics Of SAS Programming Language
Basics Of SAS Programming Language
Regression analysis
Regression analysis
Regression Analysis
Regression Analysis
SAS basics Step by step learning
SAS basics Step by step learning
Regression analysis
Regression analysis
Statistics
Statistics
Regression analysis ppt
Regression analysis ppt
Similar to Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner by Patricia B. Cerrito
Watch the video at: https://www.statsols.com/webinars/practical-methods-to-overcome-sample-size-challenges In this webinar hosted by Ronan Fitzpatrick - Head of Statistics and nQuery Lead Researcher at Statsols - we will examine some of the most common practical challenges you will experience while calculating sample size for your study. These challenges will be split into two categories: 1. Overcoming Sample Size Calculation Challenges (Survival Analysis Example) We will examine practical methods to overcome common sample size calculation issues by focusing in on one of the more complex areas for sample size determination; Survival analysis. We will cover difficulties and potential issues surrounding challenges such as: Drop Out: How to deal with expected dropouts or censoring. We compare the simple loss-to-follow-up method and integrating a dropout process into the sample size model? Planning Uncertainty: How best to deal with the inevitable uncertainty at the planning stage? We examine how best to apply a sensitivity analysis and Bayesian approaches to explore the uncertainty in your sample size calculations. Choosing the Effect Size: Various approaches and interpretations exist for how to find the effect size value. We examine those contrasting interpretations and determine the best method and also how to deal with parameterization options. 2. Overcoming Study Design Challenges (Vaccine Efficacy Example) The Randomised Controlled Trial (RCT) is considered the gold standard in trial design in drug development. However, there are often practical impediments which mean that adjustments or pragmatic approaches are needed for some trials and studies. We will examine practical methods how to overcome common study design challenges and how these affect your sample size calculations. In this webinar, we will use common issues in vaccine study design to examine difficulties surrounding issues such as: Case-Control Analysis: We will examine how to deal with study constraints and how to deal with analyses done during an observational study. Alternative Randomization Methods: How best to address randomization in your vaccine trial design when full randomization is difficult, expensive or impractical. We examine how sample size calculations are affected with cluster or Mendelian randomization. Rare Events: How does an outcome being rare affect the types of study design and statistical methods chosen in your study.
Practical Methods To Overcome Sample Size Challenges
Practical Methods To Overcome Sample Size Challenges
nQuery
Talk presented at the 1st Seminar Series in Surgical Research, School of Medicine, University of Crete (10/6/2023, Heraklion, Greece)
Common statistical pitfalls & errors in biomedical research (a top-5 list)
Common statistical pitfalls & errors in biomedical research (a top-5 list)
Evangelos Kritsotakis
About the webinar As trials increase in complexity and scope, there is a requirement for trial designs to reflect this. From dealing with non-proportional hazards in survival analysis to dealing with cluster randomization, we examine how to deal with study design issues of complex trials. In this free webinar, you will learn about: Dealing with study design issues Practical worked examples of Non-proportional Hazards Cluster Randomization Three Armed Trials Non-proportional Hazards Non-proportional hazards and complex survival curves have become of increasing interest, due to being commonly seen in immunotherapy development. This has led to interest in assessing the robustness of standard methods and alternative methods that better adapt to deviations. In this webinar, we look at methods proposed for complex survival curves and the weighted log-rank test as a candidate model to deal with a delayed survival effect. Cluster Randomization Cluster-randomized designs are often adopted when there is a high risk of contamination if cluster members were randomized individually. Stepped-wedge designs are useful in cases where it is difficult to apply a particular treatment to half of the clusters at the same time. In this webinar, we introduce cluster randomization and stepped-wedge designs to provide an insight into the requirements of more complex randomization schedules. Three Armed Trials Non-inferiority testing is a common hypothesis test in the development of generic medicine and medical devices. The most common design compares the proposed non-inferior treatment to the standard treatment alone but this leaves uncertain if the treatment effect is the same as from previous studies. This “assay sensitivity” problem can be resolved by using a three arm trial which includes placebo alongside the new and reference treatments for direct comparison. In this webinar we show a complete testing approach to this gold standard design and how to find the appropriate allocation and sample size for this study. Duration - 60 minutes Speaker: Ronan Fitzpatrick, Head of Statistics, Statsols
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
nQuery
Sample size determination
Lemeshow samplesize
Lemeshow samplesize
1joanenab
UCSF researcher, Charles McCulloch, PhD, presents. View more related presentations and resources at http://accelerate.ucsf.edu/research/cer
Analytic Methods and Issues in CER from Observational Data
Analytic Methods and Issues in CER from Observational Data
CTSI at UCSF
M. Kum Cletus Kwa a soutenu une thèse de Doctorat/Phd en mathématiques ce 14 juin 2016 à l'Université de Dschang. Le jury lui a décerné à l'issue des échanges la mention très honorable.
Probability Models for Estimating Haplotype Frequencies and Bayesian Survival...
Probability Models for Estimating Haplotype Frequencies and Bayesian Survival...
Université de Dschang
Biostatistics - the application of statistical methods in the life sciences including medicine, pharmacy, and agriculture. An understanding is needed in practice issues requiring sound decisions. Statistics is a decision science. Biostatistics therefore deals with data. Biostatistics is the science of obtaining, analyzing and interpreting data in order to understand and improve human health. Applications of Biostatistics Design and analysis of clinical trials Quality control of pharmaceuticals Pharmacy practice research Public health, including epidemiology Genomics and population genetics Ecology Biological sequence analysis Bioinformatics etc.
Soni_Biostatistics.ppt
Soni_Biostatistics.ppt
Ogunsina1
Sampling distribution of the mean
Sampling distributions
Sampling distributions
Mai Nguyen Thi Ngoc
Quantitative Synthesis I
Quantitative Synthesis I
Effective Health Care Program
This talk gives an overview and illustration of various sources of uncertainty when developing clinical risk prediction models: aleatory, approximation, model, modeler, data, and population uncertainty. Presented at the International Conference of Clinical Biostatistics, 29th of August 2023, Milan, Italy.
ISCB 2023 Sources of uncertainty b.pptx
ISCB 2023 Sources of uncertainty b.pptx
BenVanCalster
Social statistics, sociology
Hypothesis testing: A single sample test
Hypothesis testing: A single sample test
Umme Salma Tuli
Discussing, using many Bobs, how a monte carlo simulation works for a Journal Club paper regarding the modality used for detection of infectious endocarditis.
Journal Club - Discussion of Heriot et al. Criteria for identifying patients ...
Journal Club - Discussion of Heriot et al. Criteria for identifying patients ...
Salpy Kelian
Oac guidelines
Oac guidelines
Jonas Ranstam PhD
1 statistical analysis notes
1 statistical analysis notes
cartlidge
Statistics
statistics for MEDICAL RESEARH.... .pptx
statistics for MEDICAL RESEARH.... .pptx
dhivyaramesh95
Common statistical tests useful for biomedical scientists and research physicians.
Biostatistics
Biostatistics
Larry Baum
A short introduction to sample size estimation for Research methodology workshop at Dr. BVP RMC, Pravara Institute of Medical Sciences(DU), Loni by Dr. Mandar Baviskar
Basics of Sample Size Estimation
Basics of Sample Size Estimation
Mandar Baviskar
NHS Education Scotland Produced in collaboration with the Association of Scottish Medicines Information Pharmacists Group
Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011
NES
Calculation of Sample Size Analysis and Interpretation of descriptive and inferential statistics. Reporting results
Advanced Biostatistics and Data Analysis abdul ghafoor sajjad
Advanced Biostatistics and Data Analysis abdul ghafoor sajjad
HeadDPT
Displaying your results
Displaying your results
Tarek Tawfik Amin
Similar to Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner by Patricia B. Cerrito
(20)
Practical Methods To Overcome Sample Size Challenges
Practical Methods To Overcome Sample Size Challenges
Common statistical pitfalls & errors in biomedical research (a top-5 list)
Common statistical pitfalls & errors in biomedical research (a top-5 list)
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Lemeshow samplesize
Lemeshow samplesize
Analytic Methods and Issues in CER from Observational Data
Analytic Methods and Issues in CER from Observational Data
Probability Models for Estimating Haplotype Frequencies and Bayesian Survival...
Probability Models for Estimating Haplotype Frequencies and Bayesian Survival...
Soni_Biostatistics.ppt
Soni_Biostatistics.ppt
Sampling distributions
Sampling distributions
Quantitative Synthesis I
Quantitative Synthesis I
ISCB 2023 Sources of uncertainty b.pptx
ISCB 2023 Sources of uncertainty b.pptx
Hypothesis testing: A single sample test
Hypothesis testing: A single sample test
Journal Club - Discussion of Heriot et al. Criteria for identifying patients ...
Journal Club - Discussion of Heriot et al. Criteria for identifying patients ...
Oac guidelines
Oac guidelines
1 statistical analysis notes
1 statistical analysis notes
statistics for MEDICAL RESEARH.... .pptx
statistics for MEDICAL RESEARH.... .pptx
Biostatistics
Biostatistics
Basics of Sample Size Estimation
Basics of Sample Size Estimation
Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011
Advanced Biostatistics and Data Analysis abdul ghafoor sajjad
Advanced Biostatistics and Data Analysis abdul ghafoor sajjad
Displaying your results
Displaying your results
More from cambridgeWD
Dsoffercv
Dsoffercv
cambridgeWD
Delaware provision company catering services
Delaware provision company catering services
cambridgeWD
Delaware provision company custom venison
Delaware provision company custom venison
cambridgeWD
Delaware provision company main menu items
Delaware provision company main menu items
cambridgeWD
Delaware provision company retail items
Delaware provision company retail items
cambridgeWD
Retail Items
Retail Items
cambridgeWD
Custom Venison
Custom Venison
cambridgeWD
Main Menu Items
Main Menu Items
cambridgeWD
Catering Services
Catering Services
cambridgeWD
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
cambridgeWD
Proposal for Community Centre for The Seniors
Proposal for Community Centre for The Seniors
cambridgeWD
Final results from a phase III randomized study comparing DVd with VAd in fir...
Final results from a phase III randomized study comparing DVd with VAd in fir...
cambridgeWD
FlowKeepers®: Device for Enhancing Peripheral Circulation (FDA approval - pen...
FlowKeepers®: Device for Enhancing Peripheral Circulation (FDA approval - pen...
cambridgeWD
FlowKeepers®: A Device for Preventing Circulatory Ailments
FlowKeepers®: A Device for Preventing Circulatory Ailments
cambridgeWD
Oxford presentation
Oxford presentation
cambridgeWD
About Flowkeepers
About Flowkeepers
cambridgeWD
Oxford presentation
Oxford presentation
cambridgeWD
Oxford presentation
Oxford presentation
cambridgeWD
More from cambridgeWD
(18)
Dsoffercv
Dsoffercv
Delaware provision company catering services
Delaware provision company catering services
Delaware provision company custom venison
Delaware provision company custom venison
Delaware provision company main menu items
Delaware provision company main menu items
Delaware provision company retail items
Delaware provision company retail items
Retail Items
Retail Items
Custom Venison
Custom Venison
Main Menu Items
Main Menu Items
Catering Services
Catering Services
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Proposal for Community Centre for The Seniors
Proposal for Community Centre for The Seniors
Final results from a phase III randomized study comparing DVd with VAd in fir...
Final results from a phase III randomized study comparing DVd with VAd in fir...
FlowKeepers®: Device for Enhancing Peripheral Circulation (FDA approval - pen...
FlowKeepers®: Device for Enhancing Peripheral Circulation (FDA approval - pen...
FlowKeepers®: A Device for Preventing Circulatory Ailments
FlowKeepers®: A Device for Preventing Circulatory Ailments
Oxford presentation
Oxford presentation
About Flowkeepers
About Flowkeepers
Oxford presentation
Oxford presentation
Oxford presentation
Oxford presentation
Recently uploaded
By Shafna finu Ajk college of nursing Nursing student
Mgr university bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
ShafnaP5
it's an review article based on the clinical symptoms that arise after the alcohol withdrawal that can get worse in just 2 days after the withdraw of alcohol this review includes the pathophysiology and management of AWS. Management includes both the allopathic and ayurvedic Management and thus keeping in mind that the disorder can go to chronic in just 2 days treatment should be started from day 1st and giving ayurvedic formulations can be a better choice over allopathic because these can be administered for a very long time compared to allopathic and also works on the root cause of disorder clear out toxicity and person starts to recover soon. Only limitation is can not be given in chronic state.
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Yash Garg
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in. They’re like when the inside of a special part of our back pushes out a little. This can make our backs feel sore and uncomfortable. When our backs have a slipped disc, there are signs we can watch out for. First, there’s pain in one spot, like the lower back or neck. It can feel sharp and spread to other places. Then, our arms or legs might feel tingly or numb, like when they fall asleep. We might even have trouble moving some muscles or notice changes in how fast we react.
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Gokuldas Hospital
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sherrylee83
Title: Application of Checklist-Based Nursing Care Process in Patients Undergoing Intervention for Coronary Chronic Total Occlusion: A Quasi-Randomized Study Presenter: Sonia Pal, M.Sc. Nursing 2nd Year Journal: BMC Nursing (2023) Authors: Xia Ge, Haiyang Wu, Zhe Zang, and Jiayi Xie DOI: 10.1186/s12872-023-03627-8 Study Overview: This presentation focuses on the effectiveness of a checklist-based nursing care process for patients undergoing interventions for coronary chronic total occlusion (CTO). The study employs a quasi-randomized design to assess improvements in patient care outcomes. Key Points: Background: CTO interventions are complex, and traditional nursing methods have not been highly effective, necessitating the exploration of new approaches. Objective: To investigate the effectiveness of a checklist-based nursing care process in improving care quality, reducing patient anxiety, increasing patient satisfaction, and minimizing adverse events. Methodology: Design: Quasi-randomized study Setting: Department of Cardiology, Shengjing Hospital, China Medical University, Shenyang, China Participants: 120 patients undergoing CTO interventions Groups: Intervention group (checklist-based care) and control group (standard care) Tools: Preoperative and postoperative PCI nursing care checklists, Zung Self-Rating Anxiety Scale, satisfaction questionnaires for doctors and patients Ethical Considerations: The study adhered to the Declaration of Helsinki, with informed consent obtained from all participants. Results: The study aimed to demonstrate that checklist-based nursing care could enhance nursing efficiency and patient outcomes compared to conventional methods. Quality Control: A quality control team ensured adherence to the checklist and study protocol, with regular training and supervision of nursing staff. Conclusion: The presentation concludes with findings supporting the effectiveness of checklist-based nursing care in CTO interventions, suggesting improvements in patient care processes and outcomes. The study highlights the importance of structured nursing protocols in complex medical procedures.
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
Co-Chairs and Presenter Marianne Davies, DNP, ACNP, AOCNP, FAAN, Beth Sandy, MSN, CRNP, FAPO, and Matthew A. Gubens, MD, MS, FASCO, prepared useful Practice Aids pertaining to NSCLC for this CME/MOC/NCPD/ILNA/IPCE activity titled “Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3RDokbZ. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
PVI, PeerView Institute for Medical Education
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
Kanhu Charan
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
patanjali9823#S07
polymerization ,pmma, mma, swagging technique, heat cure ,self cure, light cure
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
Dr.shiva sai vemula
Explore the innovative world of Video Capsule Endoscopy (VCE) and its applications in pediatric care. This SlideShare presentation covers the procedure, benefits, and considerations for using VCE in children. Learn how this non-invasive diagnostic tool is revolutionizing the detection and treatment of gastrointestinal conditions in young patients, offering a safer and more comfortable alternative to traditional methods.
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
Raju678948
Join Dr. Muhammad Ali Rabbani, Assistant Professor of Anatomy, as he navigates through the intricate world of epithelial tissues in histology. Epithelium, comprised of closely aggregated polyhedral cells, forms cellular sheets that line organ cavities and cover body surfaces. Explore the diverse types of epithelium, their structural characteristics, and physiological functions in this enlightening session. 🔬 Key Topics Covered: - Definition and Classification: Understand the fundamental properties of epithelium and classify its various types based on structure and function. - Microscopic Examination: Learn to identify different types of simple epithelium under the microscope and sketch their histological diagrams. - Physiological Functions: Explore the principal functions of epithelial tissues, including covering, lining, protection, absorption, and secretion. 🎓 Learning Objectives: By the end of this lecture, students will: - Define epithelium and distinguish between its basic types. - Identify the histological features of simple epithelium and provide examples of each type. - Comprehend the structural components and physiological roles of the basement membrane. - Differentiate between surface epithelium and glandular epithelium. - Understand the classification, structure, and mode of secretion of glandular epithelium. 💡 Medical Applications: - Gain insights into the clinical relevance of epithelial tissues in understanding pathological conditions and disease mechanisms. - Appreciate the significance of glandular epithelium in various organ systems and secretory functions. 🔍 Connect with Dr. Muhammad Ali Rabbani to delve deeper into the histology of epithelium!🔍 Learning Resources: For additional educational content and resources, visit our website: [www.medicoseacademics.com](www.medicoseacademics.com). For inquiries, contact us at [info@medicoseacademics.com](mailto:info@medicoseacademics.com) or +92 310 7990649. 🔗 Stay Connected! Explore our content on YouTube: [Medicose Academics YouTube Channel](https://www.youtube.com/@MedicoseAcademics) Follow us on Facebook: [Medicose Academics Facebook Page](https://www.facebook.com/medicoseacademics) Connect on Instagram: [Medicose Academics Instagram](https://www.instagram.com/medicoseacademics) 🔬 Embark on a Journey through Epithelial Histology with Dr. Muhammad Ali Rabbani! 🔬 --- Tags Histology, Epithelium, Dr. Muhammad Ali Rabbani, Anatomy Lecture, Medical Education, Simple Epithelium, Basement Membrane, Glandular Epithelium, Exocrine Glands, Endocrine Glands, Paracrine Glands, Unicellular Gland, Multicellular Gland, Merocrine Gland, Apocrine Gland, Holocrine Gland, Serous Gland, Mucous Gland, Mixed Gland, Medicose Academics.
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
Umbilical cord blood vs bone marrow vs peripheral stem cells indications of stem cell transplant Regulatory requirements for cord blood banking Requirements for processing, testing and storage areas for UCB Air-handling system Personnel for Cord Blood Bank Collection of processed UCB component procedure- in utero ex utero transportation processing freezing storage screening tests quality control advantages and disadvantages labelling tissue collection live and deceased donors
Tissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood Banking
DrShinyKajal
Renal Replacement Therapy in Acute Kidney Injury -time and modality -Dr Ayman Seddik
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Ayman Seddik
Those unsightly, bulging veins on your legs might be more than just a cosmetic concern. Varicose veins can cause pain, and discomfort, and even lead to serious health complications if left untreated. Varicose veins are a common condition affecting millions of people worldwide, characterized by enlarged, twisted veins that often appear blue or dark purple on the legs.
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Gokuldas Hospital
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane Tyerman,.pdf TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane Tyerman,.pdf TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane Tyerman,.pdf
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
marcuskenyatta275
Pyoderma - definition, causes, signs and symptoms, diagnosis, management, Impetigo - definition, types, causes, signs and symptoms, diagnosis, management, Folliculitis- definition, causes, signs and symptoms, diagnosis, management, Furuncle - definition, types, causes, signs and symptoms, diagnosis, management, Carbuncles - definition, types, causes, signs and symptoms, diagnosis, management.
PYODERMA, IMPETIGO, FOLLICULITIS, FURUNCLES, CARBUNCLES.pdf
PYODERMA, IMPETIGO, FOLLICULITIS, FURUNCLES, CARBUNCLES.pdf
Dolisha Warbi
Our spinal cord has various small discs stacked one on top of another. It gives shape to our backs and creates a support system for the body to stand on. Each disc comprises a strong outer ring and a softer, gel-like inner core. When the inner part comes out through the outer ring due to injury or weakness, it results in what’s commonly referred to as a slipped, herniated, or prolapsed disc. This condition often triggers discomfort and pain.
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas Hospital
Gokuldas Hospital
- Video recording of this lecture in English language: https://www.youtube.com/watch?v=MA7nU5NWL2g&list=PLL7Q08IoVDSpg0VlGdvCHOHbXqMs0GFRe - Video recording of this lecture in Arabic language: https://www.youtube.com/watch?v=FiWabzTPFqY&list=PLL7Q08IoVDSrVcm6SmppQyefL_Ub2-xGY - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
NephroTube - Dr.Gawad
Dermatomes and myotomes and their map and test
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
niloofarbarzegari76
Mental health challenges can be overwhelming, and seeking professional help is a brave and important step. But with numerous psychiatrists in Indore, navigating the options can feel daunting. Worry not! Seeking professional help for mental health concerns is a courageous step, and finding the right psychiatrist can make all the difference.
Tips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in Indore
Gokuldas Hospital
Recently uploaded
(20)
Mgr university bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Tissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood Banking
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
PYODERMA, IMPETIGO, FOLLICULITIS, FURUNCLES, CARBUNCLES.pdf
PYODERMA, IMPETIGO, FOLLICULITIS, FURUNCLES, CARBUNCLES.pdf
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas Hospital
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
Tips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in Indore
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner by Patricia B. Cerrito
1.
Clinical Trials Versus
Health Outcomes Research: SAS/STAT Versus SAS Enterprise Miner Patricia B. Cerrito [email_address] University of Louisville
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Distribution of Patient
Stays
20.
Normal Estimate
21.
22.
Kernel Density Estimation
23.
24.
Kernel Estimate of
Length of Stay
25.
26.
27.
Sample Size=5
28.
Sample Size=30
29.
Sample Size=100
30.
Sample Size=1000
31.
Confidence Limit The
confidence limit excludes much of the actual population distribution
32.
Confidence Limit With
Larger n
33.
34.
35.
36.
Regression Equation
37.
38.
Simple Regression
39.
Classification Table
40.
Classification With 3
Variables continued...
41.
Classification With 3
Variables
42.
43.
44.
45.
46.
50/50 Split in
the Data Filter data to mortality outcome Filter data to non-mortality outcome Use PROC SURVEYSELECT to extract a subsample of non-mortality outcome Append the mortality outcome data to subsample
47.
75/25 Split in
the Data
48.
90/10 Split in
the Data
49.
50.
51.
Sampling Node
52.
Misclassification in Regression
53.
ROC Curves
54.
55.
Rule Induction Results
56.
Variable Selection
57.
58.
ROC Curves
59.
60.
61.
62.
Download now